Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | MMP8 | P22894 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | FDPS | P14324 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | PPID | Q08752 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28074164 | 0.78 | TP53 (0.50) | SLC6A2TAAR1TP53LMNACYP2D6 | |
| SCHEMBL16144804 | 0.78 | SLC6A2 (0.46) | SLC6A2TAAR1TP53LMNACYP2D6 | |
| SCHEMBL6303238 | 0.78 | SLC6A2 (0.46) | SLC6A2TAAR1TP53LMNACYP2D6 | |
| SCHEMBL28653302 | 0.77 | TAAR1 (0.50) | SLC6A2TAAR1TP53LMNACYP2D6 | |
| SCHEMBL8679105 | 0.76 | ALDH1A1 (0.38) | ALDH1A1TSHR | |
| SCHEMBL7607884 | 0.75 | TP53 (0.46) | SLC6A2TAAR1TP53LMNACYP2D6 | |
| SCHEMBL5682273 | 0.75 | SLC6A2 (0.43) | SLC6A2TAAR1TP53LMNACYP2D6 | |
| SCHEMBL5682274 | 0.75 | CYP1A2 (0.47) | SLC6A2TAAR1TP53LMNACYP2D6 | |
| SCHEMBL10624926 | 0.73 | TSHR (0.43) | SLC6A2TP53LMNAALDH1A1CYP1A2 | |
| SCHEMBL1356883 | 0.73 | SLC6A2 (0.47) | SLC6A2TAAR1TP53LMNACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9216952-B2 | Process for preparing antiviral compound | ABBVIE INC. (US) | 2015-12-22 | — | — | US | claimed |
| US-9181399-B2 | Method for producing polysiloxane | TOAGOSEI CO., LTD. (JP) | 2015-11-10 | — | — | US | claimed |
| US-20140303392-A1 | METHOD FOR PRODUCING POLYSILOXANE | TOAGOSEI CO., LTD. (JP) | 2014-10-09 | — | — | US | claimed |
| EP-2411372-B1 | PROCESS FOR PREPARING AN ANTIVIRAL COMPOUND | ABBVIE BAHAMAS LTD (BS) | 2014-07-23 | — | — | EP | claimed |
| EP-2411372-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | Abbott Laboratories (US) | 2012-02-01 | — | — | EP | claimed |
| US-20110237793-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | ABBOTT LABORATORIES (US) | 2011-09-29 | — | — | US | claimed |
| WO-2010111348-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | ABBOTT LABORATORIES (US) | 2010-09-30 | — | — | WO | claimed |
| US-20240158904-A1 | UNDERCOAT AGENT COMPOSITION FOR LAYERING INORGANIC MATERIAL LAYER, CURED PRODUCT THEREOF AND PRODUCTION METHOD THEREOF | TOAGOSEI CO., LTD. (JP) | 2024-05-16 | — | — | US | disclosed |
| US-11981828-B2 | Water repellent and oil repellent film composition and use thereof | TOAGOSEI CO. LTD. (JP) | 2024-05-14 | — | — | US | disclosed |
| CN-115103872-B | Silsesquioxane derivative and use thereof | 东亚合成株式会社 | 2024-02-02 | — | — | CN | disclosed |
| EP-4289618-A1 | UNDERCOAT AGENT COMPOSITION FOR INORGANIC SUBSTANCE LAYER LAMINATION, CURED PRODUCT THEREOF, AND METHOD FOR PRODUCING SAME | Toagosei Co., Ltd. (JP) | 2023-12-13 | — | — | EP | disclosed |
| CN-112888715-B | Silsesquioxane derivative composition and use thereof | 东亚合成株式会社 | 2023-11-03 | — | — | CN | disclosed |
| CN-116897195-A | Primer composition for inorganic substance layer lamination, cured product thereof, and method for producing same | 东亚合成株式会社 | 2023-10-17 | — | — | CN | disclosed |
| US-20140303392-A1 | METHOD FOR PRODUCING POLYSILOXANE | TOAGOSEI CO., LTD. (JP) | 2014-10-09 | — | — | US | disclosed |
| EP-2411372-B1 | PROCESS FOR PREPARING AN ANTIVIRAL COMPOUND | ABBVIE BAHAMAS LTD (BS) | 2014-07-23 | — | — | EP | disclosed |
| CN-102898456-A | O-benzyldiethoxymethylsilane and preparation method thereof | UNIV HANGZHOU NORMAL | 2013-01-30 | — | — | CN | disclosed |
| CN-102898455-A | P-benzyldiethoxymethylsilane and preparation method thereof | UNIV HANGZHOU NORMAL | 2013-01-30 | — | — | CN | disclosed |
| EP-2411372-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | Abbott Laboratories (US) | 2012-02-01 | — | — | EP | disclosed |
| US-20110237793-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | ABBOTT LABORATORIES (US) | 2011-09-29 | — | — | US | disclosed |
| WO-2010111348-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | ABBOTT LABORATORIES (US) | 2010-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110237793-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | ZC3HAV1, HAVCR2, MAVS | SLC6A2 2644/4885TAAR1 4607/4885TP53 820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.